P3 Health Partners Inc.
PIII | NASDAQ
$7.52
-$0.08 (-1.05%)
At close: Sep 22, 2026, 4:00 PM ET
$7.52
$0 (0.00%)
After-hours:
Sep 22, 2026, 7:30 PM ET
Market Data
Market Cap $24.9M
Enterprise Value $133.9M
Beta 1.62
Average Volume 1.29M
Shares Outstanding (Diluted) 3.36M
Shares Change YoY 2.91%
Institutional Ownership 7.41%
Exchange NASDAQ
ISIN US7444132044
Price Performance
Price Change 1M -26.4%
Price Change 3M -36.6%
Price Change 6M 144.4%
Price Change YTD 117.1%
Price Change 1Y -9.0%
Price Change 3Y -90.0%
Price Change 5Y -98.5%
1M CAGR (ann.) -34.4%
1Y CAGR (ann.) 0.4%
5Y CAGR (ann.) -56.6%
All-Time CAGR -53.3%
Valuation
PE Ratio -0.23
Forward PE N/A
PEG Ratio -0.01
Forward PEG -0.01
PS Ratio 0.02
Forward PS 0.00
PB Ratio 0.34
P/FCF Ratio -0.19
P/Adj. FCF Ratio -0.18
P/OCF Ratio -0.20
EV/Sales 0.09
EV/EBIT -0.80
EV/EBITDA -1.63
EV/FCF -1.03
Earnings Yield -434.2%
FCF Yield -523.8%
Adj. FCF Yield -540.7%
Financial Health
Net Debt $98.58M
Total Debt $130.27M
Cash & Short-Term Investments $21.27M
Total Assets $654.39M
Current Ratio 0.46
Quick Ratio 0.46
Debt / Equity Ratio 1.80
Debt / EBITDA -1.58
Debt / FCF -1.00
OCF / Debt -1.00
Interest Coverage -2.44
Altman Z-Score -0.28
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 31.6%
Operating Profit Margin -9.9%
EBITDA Margin -5.5%
Net Profit Margin -6.5%
FCF Margin -8.7%
Adj. FCF Margin -9.0%
SBC / Revenue 0.3%
SBC Impact (per share) -3.2%
Returns
Return on Assets -15.0%
Return on Equity 160.5%
Return on Invested Capital -51.7%
Return on Capital Employed -55.9%
Return on Tangible Assets -48.7%
Historical Growth (CAGR)
Revenue CAGR 3Y 9.7%
Revenue CAGR 5Y 22.0%
Revenue CAGR 10Y N/A
EPS CAGR 3Y -0.9%
EPS CAGR 5Y 64.5%
EPS CAGR 10Y N/A
FCF CAGR 3Y -36.5%
FCF CAGR 5Y 1.4%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 4
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Nov 11, 2026
EPS Estimate (next Q) -$3.96
EPS Growth Est (next Q) -59.0%
Revenue Est (next Q) $385.15M
Revenue Growth Est (next Q) 11.6%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $18.50
Price Target Upside 143.4%
Cash Flow
Operating Cash Flow $-130.52M
Free Cash Flow $-130.4M
Adj. Free Cash Flow $-134.63M
FCF Per Share -$38.79
OCF Per Share -$38.82
OCF/S Ratio -8.7%
Income Statement
Revenue $1.5B
Gross Profit $484.23M
Operating Income $-148.63M
EBITDA $-82.31M
Net Income $-98.44M
EPS (Diluted) -$33
Revenue / Employee $4.7M
Profit / Employee $-307.62K
Employees 320
Add to Watchlist
Select watchlists to add or remove PIII